Showing results (1441-1450 of 1,594) with videos related to
Sort By:
Pageof 160
AIDS and Behavior|March 17, 2023
Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South AfricaMookho Malahleha, Fatima Laher, Athmanundh Dilraj, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2010
Activity of IPI-504, a novel heat-shock protein 90 inhibitor, in patients with molecularly defined non-small-cell lung cancerLecia V Sequist, Scott Gettinger, Neil N Senzer, et al.HGG Advances|May 3, 2021
Long-read genome sequencing for the molecular diagnosis of neurodevelopmental disordersSusan M Hiatt, James M J Lawlor, Lori H Handley, et al.British Journal of Sports Medicine|October 20, 2018
Glucose responses to acute and chronic exercise during pregnancy: a systematic review and meta-analysisMargie H Davenport, Frances Sobierajski, Michelle F Mottola, et al.Oncogene|October 20, 2015
Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinomaM B Schabath, E A Welsh, W J Fulp, et al.Lung Cancer (Amsterdam, Netherlands)|January 19, 2021
RNA splicing and aggregate gene expression differences in lung squamous cell carcinoma between patients of West African and European ancestryApril E Deveaux, Tyler A Allen, Muthana Al Abo, et al.The Lancet. Infectious Diseases|May 17, 2011
Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b studyGlenda E Gray, Mary Allen, Zoe Moodie, et al.Clinical Lung Cancer|January 16, 2026
Optimizing Tarlatamab Delivery in Small Cell and Neuroendocrine Lung Cancer: Real-World Insights into Step-Up Dosing and Prophylactic Tocilizumab UseUtsav Joshi, Faustine Ong, Daniel Melzer, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 18, 2019
Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC-Update from PACIFICJhanelle E Gray, Augusto Villegas, Davey Daniel, et al.Environmental Health Perspectives|April 22, 1999
Screening methods for thyroid hormone disruptorsM DeVito, L Biegel, A Brouwer, et al.Pageof 160